Our results suggest that ABCB1 and ABCG2 expression might contribute to the higher doxorubicin resistance observed for the hemangiosarcoma CSF-1Rhigh cell populations; however, other transporters or mechanisms appear to be involved in drug resistance in the AS5 cell line. The gene discussed is ABCG2; the disease is angiosarcoma.